HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy

Killer-cell immunoglobulin-like receptors (KIRs) are a family of glycoproteins expressed primarily on natural killer cells that can regulate their function. Inhibitory KIRs recognize MHC class I molecules (KIR-ligands) as ligands. We have reported associations of KIRs and KIR-ligands for patients in...

Descripción completa

Detalles Bibliográficos
Autores principales: Erbe, Amy K., Wang, Wei, Reville, Patrick K., Carmichael, Lakeesha, Kim, KyungMann, Mendonca, Eneida A., Song, Yiqiang, Hank, Jacquelyn A., London, Wendy B., Naranjo, Arlene, Hong, Fangxin, Hogarty, Michael D., Maris, John M., Park, Julie R., Ozkaynak, M. F., Miller, Jeffrey S., Gilman, Andrew L., Kahl, Brad, Yu, Alice L., Sondel, Paul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466980/
https://www.ncbi.nlm.nih.gov/pubmed/28659916
http://dx.doi.org/10.3389/fimmu.2017.00675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466980/
https://www.ncbi.nlm.nih.gov/pubmed/28659916
http://dx.doi.org/10.3389/fimmu.2017.00675

Ejemplares similares